Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Onset of action of atypical and typical antipsychotics in the treatment of acute psychosis.

Mousavi SG, Rostami H, Sharbafchi MR, Boroujeni AS, Mahaki B.

J Res Pharm Pract. 2013 Oct;2(4):138-44. doi: 10.4103/2279-042X.128142.

PMID:
24991622
[PubMed]
Free PMC Article
2.

Almost all antipsychotics result in weight gain: a meta-analysis.

Bak M, Fransen A, Janssen J, van Os J, Drukker M.

PLoS One. 2014 Apr 24;9(4):e94112. doi: 10.1371/journal.pone.0094112. eCollection 2014.

PMID:
24763306
[PubMed - in process]
Free PMC Article
3.

The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Peuskens J, Pani L, Detraux J, De Hert M.

CNS Drugs. 2014 May;28(5):421-53. doi: 10.1007/s40263-014-0157-3.

PMID:
24677189
[PubMed - in process]
Free PMC Article
4.

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.

Kane JM, Kishimoto T, Correll CU.

World Psychiatry. 2013 Oct;12(3):216-26. doi: 10.1002/wps.20060.

PMID:
24096780
[PubMed]
Free PMC Article
5.

Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial.

Bossie CA, Fu DJ, Sliwa JK, Ma YW, Alphs L.

Ther Adv Psychopharmacol. 2011 Aug;1(4):111-24. doi: 10.1177/2045125311413006. Erratum in: Ther Adv Psychopharmacol. 2011 Oct;1(5):163.

PMID:
23983935
[PubMed]
Free PMC Article
6.

Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients.

Chadda RK, Ramshankar P, Deb KS, Sood M.

J Pharmacol Pharmacother. 2013 Jul;4(3):176-86. doi: 10.4103/0976-500X.114596.

PMID:
23960422
[PubMed]
Free PMC Article
7.

Treatment Response in First-episode Schizophrenia.

Schennach R, Riedel M, Musil R, Möller HJ.

Clin Psychopharmacol Neurosci. 2012 Aug;10(2):78-87. doi: 10.9758/cpn.2012.10.2.78. Epub 2012 Aug 31.

PMID:
23430971
[PubMed]
Free PMC Article
8.

Second-generation antipsychotic discontinuation in first episode psychosis: an updated review.

Miller BJ, Bodenheimer C, Crittenden K.

Clin Psychopharmacol Neurosci. 2011 Aug;9(2):45-53. doi: 10.9758/cpn.2011.9.2.45. Epub 2011 Aug 31.

PMID:
23429653
[PubMed]
Free PMC Article
9.

Antipsychotic agents: efficacy and safety in schizophrenia.

de Araújo AN, de Sena EP, de Oliveira IR, Juruena MF.

Drug Healthc Patient Saf. 2012;4:173-80. doi: 10.2147/DHPS.S37429. Epub 2012 Nov 29.

PMID:
23236256
[PubMed]
Free PMC Article
10.

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis.

Zhang JP, Gallego JA, Robinson DG, Malhotra AK, Kane JM, Correll CU.

Int J Neuropsychopharmacol. 2013 Jul;16(6):1205-18. doi: 10.1017/S1461145712001277. Epub 2012 Dec 3. Review.

PMID:
23199972
[PubMed - indexed for MEDLINE]
Free PMC Article
11.
12.

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia.

Sliwa JK, Bossie CA, Fu DJ, Turkoz I, Alphs L.

Neuropsychiatr Dis Treat. 2012;8:375-85. doi: 10.2147/NDT.S32581. Epub 2012 Aug 27.

PMID:
22956873
[PubMed]
Free PMC Article
13.

Very low-dose risperidone in first-episode psychosis: a safe and effective way to initiate treatment.

McGorry PD, Cocks J, Power P, Burnett P, Harrigan S, Lambert T.

Schizophr Res Treatment. 2011;2011:631690. doi: 10.1155/2011/631690. Epub 2011 Feb 7.

PMID:
22937271
[PubMed]
Free PMC Article
14.

A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia.

Singam AP, Mamarde A, Behere PB.

Indian J Psychol Med. 2011 Jul;33(2):134-40. doi: 10.4103/0253-7176.92061.

PMID:
22345836
[PubMed]
Free PMC Article
15.

Quantifying clinical relevance in the treatment of schizophrenia.

Correll CU, Kishimoto T, Nielsen J, Kane JM.

Clin Ther. 2011 Dec;33(12):B16-39. doi: 10.1016/j.clinthera.2011.11.016. Review.

PMID:
22177377
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics.

Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU.

Mol Psychiatry. 2013 Jan;18(1):53-66. doi: 10.1038/mp.2011.143. Epub 2011 Nov 29. Review.

PMID:
22124274
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives.

Correll CU, Kishimoto T, Kane JM.

Dialogues Clin Neurosci. 2011;13(2):155-72. Review.

PMID:
21842613
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.

Sevy S, Robinson DG, Sunday S, Napolitano B, Miller R, McCormack J, Kane J.

Psychiatry Res. 2011 Aug 15;188(3):310-4. doi: 10.1016/j.psychres.2011.05.001. Epub 2011 Jun 1.

PMID:
21636134
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Pharmacologic treatment of schizophrenia.

Kane JM, Correll CU.

Dialogues Clin Neurosci. 2010;12(3):345-57. Review.

PMID:
20954430
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Past and present progress in the pharmacologic treatment of schizophrenia.

Kane JM, Correll CU.

J Clin Psychiatry. 2010 Sep;71(9):1115-24. doi: 10.4088/JCP.10r06264yel. Review.

PMID:
20923620
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk